{"date":"2026-05-07","count":57,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4169-2026-05-07-2100-3r8dop","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"21:00:09","subject":"公告本公司認購祥翊製藥股份有限公司私募普通股","clause":"第20款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-05-07 21:00，「公告本公司認購祥翊製藥股份有限公司私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-05-07-2055-3r8dop","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"20:55:27","subject":"公告本公司認購祥翊製藥股份有限公司私募普通股","clause":"第24款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-05-07 20:55，「公告本公司認購祥翊製藥股份有限公司私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-05-07-2054-1e2j312","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"20:54:44","subject":"本公司董事會決議通過解除經理人競業禁止","clause":"第21款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-05-07 20:54，「本公司董事會決議通過解除經理人競業禁止」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-05-07-2054-9h1fdv","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"20:54:13","subject":"本公司董事會決議通過115年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-05-07 20:54，「本公司董事會決議通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-07-1929-1hq46xz","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"19:29:59","subject":"公告本公司上市掛牌首五個營業日穩定價格操作結果","clause":"第51款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-07 19:29，「公告本公司上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-07-1923-9h0ctm","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"19:23:38","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-07 19:23，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-07-1910-13m2zxy","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"19:10:33","subject":"公告本公司發言人、財務主管暨會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-07 19:10，「公告本公司發言人、財務主管暨會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-05-07-1845-1wou118","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"18:45:45","subject":"公告本公司董事會通過對子公司漢瑞投資股份有限公司現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-05-07 18:45，「公告本公司董事會通過對子公司漢瑞投資股份有限公司現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-05-07-1838-17ot8lf","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"18:38:39","subject":"代子公司漢瑞投資股份有限公司公告辦理現金增資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-05-07 18:38，「代子公司漢瑞投資股份有限公司公告辦理現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-05-07-1837-1s79axh","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"18:37:53","subject":"公告本公司115年第1季合併財務報告業經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-05-07 18:37，「公告本公司115年第1季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-05-07-1836-isqttc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"18:36:59","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-05-07 18:36，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-05-07-1815-163mvu1","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"18:15:03","subject":"依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告","clause":"第23款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-05-07 18:15，「依『公開發行公司資金貸與及背書保證處理準則』第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2026-05-07-1814-16febev","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"18:14:36","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2026-05-07 18:14，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-05-07-1802-z2cc9","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"18:02:28","subject":"公告本公司簽訂竹北廠統包工程追加工程款","clause":"第17款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-05-07 18:02，「公告本公司簽訂竹北廠統包工程追加工程款」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-05-07-1802-jhv257","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"18:02:13","subject":"公告本公司114年第一次私募普通股訂價相關事宜","clause":"第9款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-05-07 18:02，「公告本公司114年第一次私募普通股訂價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-07-1801-6lg8s4","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"18:01:40","subject":"公告本公司115年第一季合併財務報告董事會預計召開日期為115年5月15日","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-07 18:01，「公告本公司115年第一季合併財務報告董事會預計召開日期為115年5月15日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-05-07-1801-57zjbn","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"18:01:40","subject":"公告本公司副總經理異動","clause":"第11款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-05-07 18:01，「公告本公司副總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-05-07-1801-1ezkk7x","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"18:01:17","subject":"公告本公司董事會決議辦理私募現金增資發行普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-05-07 18:01，「公告本公司董事會決議辦理私募現金增資發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-05-07-1759-5rax5d","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"17:59:11","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-05-07 17:59，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-05-07-1758-b6pg53","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"17:58:11","subject":"公告本公司董事會決議召開115年股東常會相關事宜（議案增修）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-05-07 17:58，「公告本公司董事會決議召開115年股東常會相關事宜（議案增修）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-05-07-1745-xo2pc7","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"17:45:37","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-05-07 17:45，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-05-07-1744-16febev","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"17:44:45","subject":"公告本公司董事會通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-05-07 17:44，「公告本公司董事會通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-05-07-1743-dfi3en","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"17:43:32","subject":"代子公司科進製藥科技股份有限公司公告董事會通過114年度現金股利基準日及發放日","clause":"第14款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-05-07 17:43，「代子公司科進製藥科技股份有限公司公告董事會通過114年度現金股利基準日及發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-05-07-1742-1wizhdz","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"17:42:53","subject":"代子公司科進製藥科技股份有限公司公告115年第1季財務報表提報董事會","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-05-07 17:42，「代子公司科進製藥科技股份有限公司公告115年第1季財務報表提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-05-07-1732-zx5xun","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"17:32:21","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)","clause":"第32款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-05-07 17:32，「公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-05-07-1730-1nbjc38","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"17:30:27","subject":"公告本公司庫藏股買回數量達已發行股份總數百分之二","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-05-07 17:30，「公告本公司庫藏股買回數量達已發行股份總數百分之二」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2026-05-07-1712-1akre9l","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"17:12:48","subject":"公告本公司115年度第1季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：精華（1565），2026-05-07 17:12，「公告本公司115年度第1季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2026-05-07-1709-zx5xun","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"17:09:03","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)","clause":"第32款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2026-05-07 17:09，「公告本公司董事會決議召開115年股東常會相關事宜(新增召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4160-2026-05-07-1640-9h0ctm","company_id":"4160","company":"訊聯基因","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"16:40:09","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：訊聯基因（4160），2026-05-07 16:40，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-05-07-1633-jo6bfj","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"16:33:02","subject":"董事會決議辦理現金增資發行普通股參與發行海外存託憑證","clause":"第11款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-05-07 16:33，「董事會決議辦理現金增資發行普通股參與發行海外存託憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-05-07-1632-1aeuhuy","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"16:32:30","subject":"公告本公司董事會決議通過115年度第一季合併財務報表","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-05-07 16:32，「公告本公司董事會決議通過115年度第一季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4119-2026-05-07-1629-n39y2l","company_id":"4119","company":"旭富","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"16:29:49","subject":"公告本公司115年第一季財務合併報告提報董事會。","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：旭富（4119），2026-05-07 16:29，「公告本公司115年第一季財務合併報告提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-05-07-1623-1im4wr4","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"16:23:14","subject":"公告本公司新聘任策略長","clause":"第8款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-05-07 16:23，「公告本公司新聘任策略長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2026-05-07-1622-sdisny","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"16:22:33","subject":"公告本公司董事會通過115年度第一季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2026-05-07 16:22，「公告本公司董事會通過115年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-05-07-1622-1n950qy","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"16:22:22","subject":"本公司受邀參加台新證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-05-19","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-05-07 16:22，「本公司受邀參加台新證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-05-07-1609-9h1fdv","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"16:09:01","subject":"本公司董事會決議通過115年第1季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-05-07 16:09，「本公司董事會決議通過115年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-05-07-1602-hmgf2c","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"16:02:22","subject":"本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-05-07 16:02，「本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-05-07-1553-ou9fo","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:53:50","subject":"公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股剩餘股數案","clause":"第16款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-05-07 15:53，「公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股剩餘股數案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-05-07-1552-qrimme","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:52:46","subject":"公告本公司董事會通過115年第一季合併財務報告案","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-05-07 15:52，「公告本公司董事會通過115年第一季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-07-1532-1rt64uc","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:32:42","subject":"代重要子公司益興生醫股份有限公司公告董事會決議辦理現金增資發行新股事宜","clause":"第11款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-07 15:32，「代重要子公司益興生醫股份有限公司公告董事會決議辦理現金增資發行新股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-05-07-1522-17hxk3d","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:22:18","subject":"本公司董事會通過解除經理人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-05-07 15:22，「本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-05-07-1521-xo2pc7","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:21:30","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-05-07 15:21，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2026-05-07-1519-9h0ctm","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:19:52","subject":"公告本公司董事會通過115年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2026-05-07 15:19，「公告本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-05-07-1516-p67uuk","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:16:26","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-05-07 15:16，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-05-07-1515-1u0zacw","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"15:15:33","subject":"公告本公司115年第1季財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-05-07 15:15，「公告本公司115年第1季財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-07-1450-tidv3r","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"14:50:49","subject":"代重要子公司益興生醫公告持股100%之子公司Medeologix LLC及 Medeologix, Inc.間進行法定合併案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-07 14:50，「代重要子公司益興生醫公告持股100%之子公司Medeologix LLC及 Medeologix, Inc.間進行法定合」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-05-07-1444-2349lg","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"14:44:28","subject":"代重要子公司潤雅生技股份有限公司公告董事會推選 蔣永芳博士擔任董事長，並兼任總經理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-05-07 14:44，「代重要子公司潤雅生技股份有限公司公告董事會推選 蔣永芳博士擔任董事長，並兼任總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-07-1440-wsjwyz","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"14:40:53","subject":"公告本公司受邀參加凱基證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-05-15","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-07 14:40，「公告本公司受邀參加凱基證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-05-07-1420-1loui4p","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"14:20:39","subject":"公告本公司資訊安全長異動","clause":"第8款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-05-07 14:20，「公告本公司資訊安全長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6767-2026-05-07-1420-g39omu","company_id":"6767","company":"台微醫","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"14:20:03","subject":"董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：台微醫（6767），2026-05-07 14:20，「董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-05-07-1411-1wzj642","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"14:11:25","subject":"本公司股票即將終止興櫃交易並轉至臺灣證券交易所創新板上市交易","clause":"第28款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-05-07 14:11，「本公司股票即將終止興櫃交易並轉至臺灣證券交易所創新板上市交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-05-07-1405-1vqqwem","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"14:05:12","subject":"本公司辦理股票初次上市過額配售內容","clause":"第44款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-05-07 14:05，「本公司辦理股票初次上市過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-05-07-1404-1eiesrz","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-05-07","time":"14:04:31","subject":"公告本公司董事會通過115年第一季度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-05-07 14:04，「公告本公司董事會通過115年第一季度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-05-07-1401-orh8r2","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"14:01:33","subject":"公告本公司辦理股票初次上市前現金增資收足股款暨現金增資基準日","clause":"第44款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-05-07 14:01，「公告本公司辦理股票初次上市前現金增資收足股款暨現金增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-05-07-1340-hmgf2c","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"13:40:42","subject":"本公司董事會通過115年第一季合併財務報告","clause":"第31款","fact_date":"2026-05-07","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-05-07 13:40，「本公司董事會通過115年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-05-07-0959-etu2c9","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-05-07","time":"09:59:42","subject":"公告更正本公司114年度個體財務報告附表，本次更正對財報損益並無影響。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-05-07 09:59，「公告更正本公司114年度個體財務報告附表，本次更正對財報損益並無影響。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1731-2026-05-07-0844-cdfq2k","company_id":"1731","company":"美吾華","market":"上市","industry":"生技醫療","date":"2026-05-07","time":"08:44:30","subject":"公告本公司受凱基證券邀請，舉辦線上法說會","clause":"第12款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：美吾華（1731），2026-05-07 08:44，「公告本公司受凱基證券邀請，舉辦線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}